Barinthus Biotherapeutics plc American Depositary Shares (BRNS) is a publicly traded Healthcare sector company. As of August 6, 2026, BRNS trades at $0.57 with a market cap of $23.07M and a P/E ratio of -0.36. BRNS moved -0.72% today. Year to date, BRNS is -16.30%; over the trailing twelve months it is -55.81%. Its 52-week range spans $0.51 to $2.92. Rallies surfaces BRNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Barinthus Biotherapeutics plc American Depositary Shares (BRNS) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BRNS moved -0.72% today.
| Metric | Value |
|---|---|
| Price | $0.57 |
| Market Cap | $23.07M |
| P/E Ratio | -0.36 |
| EPS | $-1.64 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.92 |
| 52-Week Low | $0.51 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $506.00K |
| Net Income | $-66.46M |
| Gross Margin | 0.00% |
BRNS analyst coverage data. Average price target: $0.00.